by Maya Labat | May 27, 2021
Since their initial emergency authorization in November, monoclonal antibodies have been an important weapon in the fight against COVID-19. These products have proven to be effective at preventing hospitalization and death due to COVID-19 in some of the highest risk...
by Maya Labat | Apr 27, 2021
Antimicrobial resistance may have increased during COVID-19 pandemic due to the medications being used to treat the virus including steroids and other immune-suppressive medications, longer hospital length of stay, ICU length of stay, and duration of mechanical...
